Aptinyx (APTX)

4.00 -0.02 (0.50%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (2/12/21 *Est.)

Latest Headlines

Aptinyx Announces Publication of Review Article Highlighting Preclinical Data in Medicine in Drug Discovery Demonstrating the Potential of NYX-2925 to Treat Chronic, Centralized Pain Conditions January 19, 2021 8:31 AM - BizWire Form 4 Aptinyx Inc. For: Dec 31 Filed by: Koppel Adam January 5, 2021 4:44 PM - SEC Filing Form 4 Aptinyx Inc. For: Dec 31 Filed by: HOMBACH ROBERT J. January 5, 2021 4:32 PM - SEC Filing Form 4 Aptinyx Inc. For: Dec 31 Filed by: Gosebruch Henry O January 5, 2021 4:32 PM - SEC Filing Form 4 Aptinyx Inc. For: Dec 31 Filed by: Gould Terry P January 5, 2021 4:32 PM - SEC Filing Form 4 Aptinyx Inc. For: Dec 31 Filed by: ENRIGHT PATRICK G January 5, 2021 4:32 PM - SEC Filing Aptinyx to Participate in H.C. Wainwright BioConnect 2021 Conference January 5, 2021 8:37 AM - BizWire Aptinyx (APTX) Announces Recommencement of Phase 2 Study of NYX-2925 in Patients With Painful Diabetic Peripheral Neuropathy January 4, 2021 7:59 AM - StreetInsider Aptinyx Announces Recommencement of Phase 2 Study of NYX-2925 in Patients With Painful Diabetic Peripheral Neuropathy January 4, 2021 7:57 AM - BizWire Aptinyx to Present at the 39th Annual J.P. Morgan Healthcare Conference December 21, 2020 8:30 AM - BizWire Form 8-K Aptinyx Inc. For: Dec 16 December 16, 2020 4:34 PM - SEC Filing Form 4 Aptinyx Inc. For: Dec 14 Filed by: KIDD ANDREW December 16, 2020 4:30 PM - SEC Filing Aptinyx Appoints Andy Kidd, M.D., President and Chief Operating Officer December 16, 2020 8:30 AM - BizWire Form 10-Q Aptinyx Inc. For: Sep 30 November 12, 2020 4:31 PM - SEC Filing Form 8-K Aptinyx Inc. For: Nov 12 November 12, 2020 4:06 PM - SEC Filing Aptinyx (APTX) Tops Q3 EPS by 5c, Revenues Miss November 12, 2020 4:05 PM - StreetInsider Aptinyx Reports Third Quarter 2020 Financial Results and Recent Highlights November 12, 2020 4:03 PM - BizWire Aptinyx to Participate in Upcoming Virtual Investor Conferences November 10, 2020 8:37 AM - BizWire Aptinyx to Report Third Quarter Financial Results on Thursday, November 12, 2020 October 29, 2020 8:37 AM - BizWire Form 4 Aptinyx Inc. For: Oct 26 Filed by: Schwartz Jeffrey Lawrence October 27, 2020 5:08 PM - SEC Filing Form SC 13D/A Aptinyx Inc. Filed by: Bain Capital Life Sciences Fund, L.P. October 27, 2020 4:24 PM - SEC Filing Piper Sandler Starts Aptinyx (APTX) at Overweight October 27, 2020 4:19 AM - StreetInsider Aptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option October 26, 2020 4:01 PM - BizWire Full Article List